Marva Mitchell Sprual, NP
Family · Hackensack, NJNPI 1164030045
Payments from drug & device makers
Across 23 payments — averaging $104.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$492
- AstraZeneca$401
- Alnylam Pharmaceuticals Inc.$312
- Gilead$237
- Cipher Pharmaceuticals US LLC$154
- Sun Pharmaceutical Industries Inc.$142
- plus $672 from 7 others
What the payments were for
- Food & beverage$2,411100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $492 |
| AstraZeneca | 4 | $401 |
| Alnylam Pharmaceuticals Inc. | 3 | $312 |
| Gilead | 2 | $237 |
| Cipher Pharmaceuticals US LLC | 1 | $154 |
| Sun Pharmaceutical Industries Inc. | 1 | $142 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Johnson & Johnson | 1 | $112 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| Mylan Specialty L.p. | 1 | $90 |
| Coloplast | 1 | $88 |
| Inspire Medical Systems, Inc. | 1 | $85 |
| Acadia Pharmaceuticals Inc | 2 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$247
- ABILIFY MAINTENA$245
- ABILIFY ASIMTUFII$245
- Natroba$154
- SPINOSAD$154
- DRIZALMA SPRINKLE$142
- ONPATTRO$135
- Descovy$128
- DUPIXENT$122
- FASENRA$114
- INVEGA$112
- Yeztugo$110
How this compares
$2,411 in reported general payments places this provider in the 85th percentile of 2,692 family providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 25 | $670 |
| Atorvastatin Calcium | 39 | $560 |
| Oxycodone Hcl | 23 | $455 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $375 |
| Levothyroxine Sodium | 28 | $311 |
| Duloxetine Hcl | 11 | $291 |
| Morphine Sulfate ErMorphine Sulfate | 17 | $289 |
| Mirtazapine | 22 | $253 |
| Tramadol Hcl | 20 | $234 |
| Lorazepam | 18 | $202 |
| Amlodipine Besylate | 26 | $181 |
| Fluticasone Propionate | 11 | $157 |
| Pantoprazole Sodium | 22 | $142 |
| Alprazolam | 11 | $137 |
| Spironolactone | 13 | $131 |
Paid to pharmacies, not to this prescriber.
Other family in Hackensack
- Bianca CorsiHackensack$9K
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- Angie GarciaWest New York$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.